3.22 USD
+0.17 (+5.57%)
At close: Feb 6, 2026
3.16 USD
-0.06 (-1.86%)
After Hours: 2/6/2026, 8:03:36 PM
REAX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 62 industry peers in the Real Estate Management & Development industry. The financial health of REAX is average, but there are quite some concerns on its profitability. REAX is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
- In the past year REAX has reported negative net income.
- In the past year REAX had a positive cash flow from operations.
- In the past 5 years REAX always reported negative net income.
- Of the past 5 years REAX 4 years had a positive operating cash flow.
1.2 Ratios
- REAX's Return On Assets of -7.28% is on the low side compared to the rest of the industry. REAX is outperformed by 66.13% of its industry peers.
- REAX has a Return On Equity of -19.54%. This is in the lower half of the industry: REAX underperforms 61.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.28% | ||
| ROE | -19.54% | ||
| ROIC | N/A |
ROA(3y)-40.4%
ROA(5y)-33.37%
ROE(3y)-84.35%
ROE(5y)-71.32%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- REAX's Gross Margin of 8.64% is on the low side compared to the rest of the industry. REAX is outperformed by 64.52% of its industry peers.
- REAX's Gross Margin has declined in the last couple of years.
- REAX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 8.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y-6.44%
2. Health
2.1 Basic Checks
- REAX does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for REAX has been increased compared to 1 year ago.
- REAX has more shares outstanding than it did 5 years ago.
- REAX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- REAX has an Altman-Z score of 15.71. This indicates that REAX is financially healthy and has little risk of bankruptcy at the moment.
- With an excellent Altman-Z score value of 15.71, REAX belongs to the best of the industry, outperforming 96.77% of the companies in the same industry.
- REAX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 15.71 |
ROIC/WACCN/A
WACC8.86%
2.3 Liquidity
- REAX has a Current Ratio of 1.36. This is a normal value and indicates that REAX is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.36, REAX is doing worse than 64.52% of the companies in the same industry.
- REAX has a Quick Ratio of 1.36. This is a normal value and indicates that REAX is financially healthy and should not expect problems in meeting its short term obligations.
- REAX has a worse Quick ratio (1.36) than 61.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.36 |
3. Growth
3.1 Past
- REAX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 77.78%, which is quite impressive.
- Looking at the last year, REAX shows a very strong growth in Revenue. The Revenue has grown by 65.60%.
- Measured over the past years, REAX shows a very strong growth in Revenue. The Revenue has been growing by 140.25% on average per year.
EPS 1Y (TTM)77.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)65.6%
Revenue growth 3Y118.22%
Revenue growth 5Y140.25%
Sales Q2Q%52.64%
3.2 Future
- REAX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.37% yearly.
- REAX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 32.33% yearly.
EPS Next Y63.57%
EPS Next 2Y36.17%
EPS Next 3Y31.37%
EPS Next 5YN/A
Revenue Next Year59.69%
Revenue Next 2Y39.47%
Revenue Next 3Y32.33%
Revenue Next 5YN/A
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for REAX. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for REAX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Price/Free Cash Flow ratio, REAX is valued cheaper than 91.94% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.3 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- REAX's earnings are expected to grow with 31.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.17%
EPS Next 3Y31.37%
5. Dividend
5.1 Amount
- REAX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
3.22
+0.17 (+5.57%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)03-04 2026-03-04/bmo
Inst Owners43.9%
Inst Owner Change-1.27%
Ins Owners11.42%
Ins Owner ChangeN/A
Market Cap682.00M
Revenue(TTM)1.81B
Net Income(TTM)-10.55M
Analysts86
Price Target6.04 (87.58%)
Short Float %3.55%
Short Ratio4.07
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)196.08%
Min EPS beat(2)100%
Max EPS beat(2)292.16%
EPS beat(4)4
Avg EPS beat(4)120.81%
Min EPS beat(4)34.64%
Max EPS beat(4)292.16%
EPS beat(8)6
Avg EPS beat(8)53.29%
EPS beat(12)8
Avg EPS beat(12)36.56%
EPS beat(16)11
Avg EPS beat(16)27.77%
Revenue beat(2)2
Avg Revenue beat(2)7.15%
Min Revenue beat(2)4.42%
Max Revenue beat(2)9.88%
Revenue beat(4)4
Avg Revenue beat(4)8.27%
Min Revenue beat(4)4.24%
Max Revenue beat(4)14.54%
Revenue beat(8)8
Avg Revenue beat(8)11.77%
Revenue beat(12)12
Avg Revenue beat(12)13.69%
Revenue beat(16)16
Avg Revenue beat(16)19.94%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-44.44%
EPS NY rev (1m)-11.11%
EPS NY rev (3m)-11.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.02%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)2.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.38 | ||
| P/FCF | 10.3 | ||
| P/OCF | 9.74 | ||
| P/B | 12.87 | ||
| P/tB | 17.27 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.04
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0.31
FCFY9.71%
OCF(TTM)0.33
OCFY10.26%
SpS8.56
BVpS0.25
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.28% | ||
| ROE | -19.54% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 8.64% | ||
| FCFM | 3.65% |
ROA(3y)-40.4%
ROA(5y)-33.37%
ROE(3y)-84.35%
ROE(5y)-71.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y-6.44%
F-Score7
Asset Turnover12.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 219.77% | ||
| Cap/Sales | 0.21% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1.36 | ||
| Altman-Z | 15.71 |
F-Score7
WACC8.86%
ROIC/WACCN/A
Cap/Depr(3y)186.01%
Cap/Depr(5y)132.24%
Cap/Sales(3y)0.18%
Cap/Sales(5y)0.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y63.57%
EPS Next 2Y36.17%
EPS Next 3Y31.37%
EPS Next 5YN/A
Revenue 1Y (TTM)65.6%
Revenue growth 3Y118.22%
Revenue growth 5Y140.25%
Sales Q2Q%52.64%
Revenue Next Year59.69%
Revenue Next 2Y39.47%
Revenue Next 3Y32.33%
Revenue Next 5YN/A
EBIT growth 1Y65.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year321.46%
EBIT Next 3Y78.43%
EBIT Next 5YN/A
FCF growth 1Y212.51%
FCF growth 3Y133.43%
FCF growth 5YN/A
OCF growth 1Y216.48%
OCF growth 3Y131.69%
OCF growth 5YN/A
REAL BROKERAGE INC/THE / REAX FAQ
What is the fundamental rating for REAX stock?
ChartMill assigns a fundamental rating of 4 / 10 to REAX.
Can you provide the valuation status for REAL BROKERAGE INC/THE?
ChartMill assigns a valuation rating of 2 / 10 to REAL BROKERAGE INC/THE (REAX). This can be considered as Overvalued.
Can you provide the profitability details for REAL BROKERAGE INC/THE?
REAL BROKERAGE INC/THE (REAX) has a profitability rating of 1 / 10.
What is the financial health of REAL BROKERAGE INC/THE (REAX) stock?
The financial health rating of REAL BROKERAGE INC/THE (REAX) is 6 / 10.
What is the earnings growth outlook for REAL BROKERAGE INC/THE?
The Earnings per Share (EPS) of REAL BROKERAGE INC/THE (REAX) is expected to grow by 63.57% in the next year.